CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The new online Learning Center with new content can still be found under the “Training” folder on ...